The main drug classes used for the management of DR and other DM related complications are anti-vascular endothelial growth factor (anti-VEGF) drugs, protein kinase C (PKC) inhibitors, corticosteroids, and somatostatin analogues [1]. The gene discussed is VEGFA; the disease is diabetes mellitus.